Old Web
English
Sign In
Acemap
>
authorDetail
>
Shilpa Surendran
Shilpa Surendran
Singapore General Hospital
Medicine
Immunology
Multiple myeloma
Diabetes mellitus
Bortezomib
4
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution
2016
International Journal of Hematology
Hae Tha Mya
Hui Ming Tay
Shien Wen Gan
Shilpa Surendran
Shu Hui Yeang
Cynthia C. Lim
Hui-Lin Choong
Lai Heng Lee
Heng Joo Ng
Show All
Source
Cite
Save
Citations (3)
Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group
2016
Bone Marrow Transplantation
Shin Yeu Ong
S. de Mel
Yunxin Chen
Melissa G. Ooi
Shilpa Surendran
Adeline Lin
Liang Piu Koh
Yeh-Ching Linn
Aloysius Ho
William Ying Khee Hwang
C Phipps
S M Y Loh
Yeow-Tee Goh
Daryl Tan
Wee Joo Chng
Sathish Gopalakrishnan
Show All
Source
Cite
Save
Citations (13)
Bortezomib Based Induction Is Superior to Thalidomide Based Induction in Reducing Early Relapses Following Upfront HDM: an Analysis By the Asian Myeloma Working Group
2016
Blood
Sathish Gopalakrishnan
Shin Yeu Ong
Seok Jin Kim
Hae Su Kim
Ji Yun Lee
Sung Hee Lim
Yunxin Chen
Sanjay de Mel
Melissa G. Ooi
Shilpa Surendran
Adeline Lin
Daryl Tan
Brian G. M. Durie
Wee Joo Chng
Kihyun Kim
Show All
Source
Cite
Save
Citations (0)
Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma
2015
British Journal of Haematology
Shin Yeu Ong
Hong-Yen Ng
Shilpa Surendran
Yeh-Ching Linn
Yunxin Chen
Yeow-Tee Goh
Colin Phipps Diong
Sathish Gopalakrishnan
Show All
Source
Cite
Save
Citations (9)
1